Agios Pharmaceuticals

Employees:
290
Market Cap:
$2.39 billion
Revenue:
$69.95 million
5 Year Trend:
26.2%
Net Income:
$-212.78 million
NASDAQ:
AGIO

Agios Pharmaceuticals is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. Wikipedia

Agios Pharmaceuticals
Employees:
290
Market Cap:
$2.39 billion
Revenue:
$69.95 million
5 Year Trend:
26.2%
Net Income:
$-212.78 million
NASDAQ:
AGIO

Agios Pharmaceuticals is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. Wikipedia

15

Agios Pharmaceuticals jobs